Management of chronic myeloid leukemia (CML) has undergone a sea change over the last couple of decades with the advent of targeted therapies. Tyrosine kinase
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
